TJ is a commercial leader with over 25 years of experience in both the pharmaceutical and biotech industries. She started her career at larger companies such as Eli Lilly and with her entrepreneurial mindset, gravitated to smaller, Canadian start-up organizations such as Alexion and Mitsubishi Tanabe Pharma.

EmpowerPharm is delighted to announce the appointment of Mr. Chirag Shah who will join our Company as our Vice President Pharmaceutical Development on June 21st. Chirag will lead our development initiatives.

EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today May 13th, 2022 that the U.S. Food and Drug Administration (FDA) has provided clearance to proceed with the Company’s Investigational New Drug (IND)

Health Canada has certified the first ever Canadian-owned pharmaceutical facility for the manufacture of prescription products containing cannabidiol (CBD) This marks the first Health Canada

Dr. Anat Fields has worked in pharmaceutical companies for more than 20 years, yet when she talks about her current work a developing a first-of-its-kind

Our recently appointed Senior Medical Consultant, Dr. Murray B. Stein, connected with us to discuss his body of work, expertise in psychiatry, and overall perspective

Today is Blue Monday, the so-called most depressing day of the year. While the science behind Blue Monday may be anectodal, seasonal affective disorder (SAD)

The holidays can be a difficult time of year for many Canadians, especially with the ongoing COVID-19 pandemic making people feel more isolated than ever,

EmpowerPharm Inc., the first wholly Canadian-owned and operated pharmaceutical company established in recent years, is pleased to announce the appointment of Dr. Murray B Stein

Our state-of-the-art manufacturing facility is making headlines. Politicians from all three levels of government – municipal, provincial, and federal – are visiting the facility to